ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
With reference to the captioned subject, please find enclosed herewith the intimation dated 15th June, 2023 received from Link lntime India Private Limited, Registrar and Share Transfer Agent, regarding receipt of the request(s)/application(s) from the registered shareholder(s) of the Company for issue of Duplicate Share Certificate(s). ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
With reference to the captioned subject, please find enclosed herewith the intimation dated 14th June, 2023, received from Link lntirne India Private Limited, Registrar and Share Transfer Agent, regarding receipt of the request(s)/application(s) from the registered shareholder(s) of the Company for issue of Duplicate Share Certificate(s). ALEMBIC PHARMACEUTICALS LTD. - 533573 - Clarification On Increase In Volume
With reference to the captioned matter and your above referred e-mail, we would like to state that the Company has made all the necessary disclosures pursuant to the provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and has not withheld any material information / event that in our opinion would have a bearing on the price/ volume of the security of the Company. The significant movement in the volume of the security of the Company is purely market driven. We request you to kindly take the same on record. ALEMBIC PHARMACEUTICALS LTD. - 533573 - Clarification sought from Alembic Pharmaceuticals Ltd
The Exchange has sought clarification from Alembic Pharmaceuticals Ltd on June 9, 2023, with reference to Movement in Volume.The reply is awaited. ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
With reference to the captioned subject, please find enclosed herewith the intimation dated 8th June, 2023 received from Link lntime India Private Limited, Registrar and Share Transfer Agent, regarding approval of the request received for issue of Duplicate Share Certificate(s) and issue of letter of confirmation in lieu of the physical share certificate to the registered shareholder(s) in accordance with the provisions of SEBI Circular No. SEBI/HO/MIRSD/MIRSD_RTAMB/P/CIR/2022/8 dated 25th January, 2022. ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Newspaper Publication
With reference to the captioned subject, we enclose herewith a copy of the advance notice published in 'Economic Times & Indian Express (English Edition) and Financial Express (Gujarati Edition) on 5th June, 2023, in compliance with the procedure prescribed vide various circulars issued from time to time by Ministry of Corporate Affairs and Securities and Exchange Board of India, inter alia informing the members that the 13th Annual General Meeting of the Company will be held on Friday, the 4th August, 2023 through Video Conferencing / Other Audio Visual Means. ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
With reference to the captioned subject, please find enclosed herewith the intimation dated 2nd June, 2023, received from Link lntime India Private Limited, Registrar and Share Transfer Agent, regarding receipt of the request(s)/application(s) from the registered shareholder(s) of the Company for issue of Duplicate Share Certificate(s). ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform that the management of the Company shall be meeting analysts/investors through Trinity India -2023 Annual Investor Conference hosted by Batlivala & Karani Securities India Pvt. Ltd. ('B&K') on 1st June, 2023. ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform that the management of the Company shall be meeting analysts/investors through Trinity India -2023 Annual Investor Conference hosted by Batlivala & Karani Securities India Pvt. Ltd. ('B&K') on 1st June, 2023. ALEMBIC PHARMACEUTICALS LTD. - 533573 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ("Listing Regulations, 2015")
Pursuant to Regulation 30 of the Listing Regulations, 2015, please find enclosed herewith a specimen copy of the letter (excluding the annexure) sent to the shareholders holding shares in physical form, in compliance with the provisions of SEBI Circular No. SEBI/HO/MIRSD/MIRSD-PoD-1/P/CIR/2023/37 dated March 16, 2023, requesting them to furnish their PAN, KYC details and Nomination details (including declaration to opt out) to the Registrar and Share Transfer Agent of the Company, i.e. Link lntime India Private Limited. Further, in compliance with the aforesaid SEBI Circular, the Company has also placed the communication/intimation in this regard on its website at https://alembicpharmaceuticals.com/